
1. Sci Rep. 2021 Dec 1;11(1):23235. doi: 10.1038/s41598-021-02592-6.

A clinical, aetiological, and public health perspective on central nervous system
infections in Bolivia, 2017-2018.

Saba Villarroel PM(1)(2), Castro Soto MDR(3), Melendres Flores O(4), Peralta
Landívar A(5), Calderón ME(6), Loayza R(7), Boucraut J(8)(9), Thirion L(10),
Dubot-Pérès A(10), Ninove L(10), de Lamballerie X(10).

Author information: 
(1)Unité des Virus Émergents (UVE: Aix-Marseille Univ.-IRD 190-INSERM 1207-IHU
Méditerranée Infection), 13005, Marseille, France. marielasaba@gmail.com.
(2)Molecular Biology Unit, Centro Nacional de Enfermedades Tropicales (CENETROP),
Santa Cruz de la Sierra, Bolivia. marielasaba@gmail.com.
(3)Infectology Department, Viedma Hospital, Cochabamba, Bolivia.
(4)Neurology Department, Dr. Mario Ortíz Suárez Hospital, Santa Cruz de la
Sierra, Bolivia.
(5)Neurology Department, Japonés Hospital, Santa Cruz de la Sierra, Bolivia.
(6)Infectology Department, Manuel Ascencio Villarroel Hospital, Cochabamba,
Bolivia.
(7)Molecular Biology Unit, Centro Nacional de Enfermedades Tropicales (CENETROP),
Santa Cruz de la Sierra, Bolivia.
(8)Immunology Laboratory, Conception Hospital, 13005, Marseille, France.
(9)Timone Neuroscience Institute, Aix-Marseille University, 13005, Marseille,
France.
(10)Unité des Virus Émergents (UVE: Aix-Marseille Univ.-IRD 190-INSERM 1207-IHU
Méditerranée Infection), 13005, Marseille, France.

Central nervous system (CNS) infections are important causes of morbidity and
mortality worldwide. In Bolivia, aetiologies, case fatality, and determinants of 
outcome are poorly characterised. We attempted to investigate such parameters to 
guide diagnosis, treatment, prevention, and health policy. From Nov-2017 to
Oct-2018, we prospectively enrolled 257 inpatients (20.2% HIV-positive patients) 
of all ages from healthcare centers of Cochabamba and Santa Cruz, Bolivia with a 
suspected CNS infection and a lumbar puncture performed. Biological diagnosis
included classical microbiology, molecular, serological and immunohistochemical
tests. An infectious aetiology was confirmed in 128/257 (49.8%) inpatients,
including, notably among confirmed single and co-infections, Cryptococcus spp.
(41.7%) and Mycobacterium tuberculosis (27.8%) in HIV-positive patients, and
Mycobacterium tuberculosis (26.1%) and Streptococcus pneumoniae (18.5%) in
HIV-negative patients. The total mortality rate was high (94/223, 42.1%),
including six rabies cases. In multivariate logistic regression analysis,
mortality was associated with thrombocytopenia (Odds ratio (OR) 5.40, 95%-CI
2.40-11.83) and hydrocephalus (OR 4.07, 95%-CI 1.35-12.23). The proportion of
untreated HIV patients, late presentations of neurotuberculosis, the rate of
pneumococcal cases, and rabies patients who did not benefit from a post-exposure 
prophylaxis, suggest that decreasing the burden of CNS infections requires
reinforcing health policy regarding tuberculosis, rabies, S. pneumoniae
vaccination, and HIV-infections.

© 2021. The Author(s).

DOI: 10.1038/s41598-021-02592-6 
PMCID: PMC8636643
PMID: 34853372 

